Wedbush Forecasts Nuvation Bio’s Q3 Earnings (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Investment analysts at Wedbush reduced their Q3 2025 earnings estimates for Nuvation Bio in a research report issued to clients and investors on Monday, March 3rd. Wedbush analyst D. Nierengarten now expects that the company will earn ($0.17) per share for the quarter, down from their prior […]
Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Investment analysts at Wedbush reduced their Q3 2025 earnings estimates for Nuvation Bio in a research report issued to clients and investors on Monday, March 3rd. Wedbush analyst D. Nierengarten now expects that the company will earn ($0.17) per share for the quarter, down from their prior […]
